Loading data for CAMLF — first visit, this takes a few seconds.

Central Asia Metals plc (CAMLF)

OTC Markets OTCPK: CAMLF · 即時價格 · USD

2.75

+0.00 (0.00%)

收盤價： Sep 04, 2026, 8:00 PM

提醒

Alert

股價、關鍵數字和最新消息，都在這一頁。

無可用資料

買價	2
市值	469M
營收 (ttm)	276M
淨利（ttm）	-45.7M
	1.21
	-0.25
	n/a
	n/a
P/B (ttm)	1.60
P/S (ttm)	1.70
財報日期	n/a

賣價	2.65
成交量	300
20 日平均成交量	2,857
開盤價	2.47
前收盤價	2.75
當日區間	2.47 - 2.47
52 週範圍	1.68 - 3.59
分析師	n/a
目標價	n/a
股利	$0.21 (7.57%)
除息日	Sep 24, 2026

關於 CAMLF

Central Asia Metals plc, together with its subsidiaries, operates as a base metals producer. The company produces copper, zinc, silver, and lead minerals. It also owns a 100% interest in the Kounrad solvent extraction-electrowinning operation located near the city of Balkhash in central Kazakhstan; and in the Sasa mine located in north Macedonia. Central Asia Metals plc was incorporated in 2005 and is headquartered in London, the United Kingdom....

[閱讀更多]

產業 Copper

類股 Basic Materials

IPO 日期 Sep 3, 2021

員工 717

證券交易所 OTC Markets OTCPK

股票代號 CAMLF

網站 https://www.centralasiametals.com

完整的公司簡介

財務表現

Central Asia Metals plc 在 2025 年的營收為 229.86M，較前一年的 214.44M 增加 7.19%。淨利為 -75.05M，較前期減少 -246.03%。

財務報表

財報驚奇

Central Asia Metals plc 已於 Invalid Date 公布季度財報：

營收為 n/a 低於預期 $0, 年增 NaN% 成長.
每股盈餘為低於預期 , 年增 NaN% 成長.

價格為何變動

新聞動態

1 週前 · GuruFocus.com

Central Asia Metals PLC (CAMLF) (H1 2026) Earnings Call Highlights: Record EBITDA and Strategic ...

Central Asia Metals PLC (CAMLF) reports a 89% surge in EBITDA to $75.5 million, driven by strong commodity prices and operational improvements, while advancing its growth pipeline.

1 週前 · Proactive

Central Asia Metals CEO: 'Really positive' H1 as Cygnus deal and drill assays loom

Central Asia Metals PLC (AIM:CAML, OTC:CAMLF) CEO Gavin Ferrar spoke with Proactive's Stephen Gunnion about the company's strong first-half 2026 performance, the proposed acquisition of Cygnus Metals,...

1 週前 · Proactive

Faron Pharmaceuticals, Central Asia Metals, Gelion, S&U, Mila Resources, Georgina Energy

Faron Pharmaceuticals Limited (AIM:FARN) is set to start its phase IIb BEXERA trial for blood cancer drug bexmarilimab in the second half of this year. It'll test the drug in 90 patients across the US...

1 週前 · Proactive

Central Asia Metals says revenue jumped 46% boosted by higher prices and higher volumes

Central Asia Metals PLC (AIM:CAML, OTC:CAMLF) shares climbed close to 10% in Wednesday's trade after it nearly doubled first-half earnings (EBITDA) and lifted its interim dividend to 8p as higher copp...

2 月前 · Simply Wall St.

Central Asia Metals (AIM:CAML) Stock Fair Value Falls After Analyst Downgrade

Central Asia Metals is under fresh scrutiny after the stock’s fair value estimate was revised from £2.20 to £1.82, a change of about 17% that reshapes how some investors may look at its potential. Ana...

第 1 頁，共 2 頁

Central Asia Metals plc (CAMLF)